As of January 22, 2025, ARS Pharmaceuticals (SPRY) has a market cap of $1.32 billion USD. According to our data, ARS Pharmaceuticals is ranked No.4783 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.32 B |
28.44%
|
Dec 31, 2024 | $1.03 B |
92.52%
|
Dec 29, 2023 | $0.53 B |
-35.76%
|
Dec 30, 2022 | $0.83 B |
28.08%
|
Dec 31, 2021 | $0.65 B |
-85.63%
|
Dec 31, 2020 | $4.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | SPRY Stock Price | * | SPRY Shares Outstanding |
= | $13.55 | * | 97.19 M | |
= | $1.32 B |